Please note that medicinal cannabis consultations are not intended for the diagnosis of a condition. Some patients may require an additional appointment at a charge if further assessment is necessary.
Patients should inform the clinic that they wish to participate in Project Twenty21 before their consultation. When contacting a clinic make it very clear that you are a Twenty21 patient to access subsidised products.
Any products prescribed which are not included in Project Twenty21 are not subsidised and will incur prescription, dispensing and delivery costs.
Before scheduling a consultation, most clinics offer a pre-assessment involving a review of patient healthcare records. Please check with individual clinics as to whether there is a charge for this.
Consultations will either be conducted remotely via telemedicine (access to video calling required) or face to face.
Patients must ensure that the doctor is aware they wish to participate in Project Twenty21.
The doctor will complete an initial assessment and questionnaire covering:
Previous and current medications for a condition
Other therapies which have been undertaken
How symptoms affect the patient’s quality of life e.g. impact on sleep, mobility etc…
Any previous cannabis use, including cannabis-based products. The clinician should be informed of:
1. What has been most effective at managing symptoms?
2. How this is taken – by oil, edibles, balm, smoking or vaporizing?
3. Any issues or side effects experienced from using cannabis previously
The doctor will decide whether to prescribe medicinal cannabis products based on the patients’ medical history and clinical need.
Attending a consultation does not guarantee a medical cannabis prescription will be provided.
Clinics will determine the frequency and cost of follow up consultation, with data collection occurring every 3 months. Patients must attend follow-up consultations to continue receiving their medication.